Corteva (CTVA) Stock Forecast & Price Target

$61.21 -1.23 (-1.97%)

As of 10:23 AM Eastern

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
1

Hold
4

Buy
13

Based on 18 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 1 has given a sell rating, 4 have given a hold rating, and 13 have given a buy rating for CTVA.

Consensus Price Target

$68.00
11.09% Upside

According to the 18 analysts' twelve-month price targets for Corteva, the average price target is $68.00. The highest price target for CTVA is $74.00, while the lowest price target for CTVA is $55.00. The average price target represents a forecasted upside of 11.09% from the current price of $61.21.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

CTVA Analyst Ratings Over Time

Type	Current Forecast 3/28/24 to 3/28/25	1 Month Ago 2/27/24 to 2/26/25	3 Months Ago 12/29/23 to 12/28/24	1 Year Ago 3/29/23 to 3/28/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$68.00	$67.73	$65.41	$63.14
Forecasted Upside	11.09% Upside	8.11% Upside	14.28% Upside	9.49% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.67	2.50	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	11.09% Upside	54.26% Upside	18.82% Upside
News Sentiment Rating	Positive News See Recent CTVA News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/13/2025	The Goldman Sachs Group 3 of 5 stars	Duffy Fischer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$71.00	+20.19%
2/11/2025	Bank of America 3 of 5 stars	Steve Byrne Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$69.00 ➝ $73.00	+17.36%
2/10/2025	BNP Paribas 3 of 5 stars	L. Favre Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
2/7/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$72.00 ➝ $73.00	+17.09%
2/7/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kristen Owen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$70.00 ➝ $72.00	+14.94%
2/7/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aleksey Yefremov Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$68.00 ➝ $70.00	+8.77%
1/29/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Cunningham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$69.00 ➝ $74.00	+14.32%
1/28/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$67.00 ➝ $73.00	+13.26%
1/21/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$62.00 ➝ $64.00	+2.74%
1/10/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$74.00 ➝ $73.00	+27.56%
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
9/24/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$65.00 ➝ $65.00	+12.67%
8/7/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Selesky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/2/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$57.00 ➝ $55.00	+6.63%
6/18/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$61.00 ➝ $60.00	+15.27%
6/12/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$65.00 ➝ $65.00	+25.90%
6/7/2024	OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Mixed ➝ Negative
5/3/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $65.00	+13.72%
5/3/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$64.00 ➝ $67.00	+17.13%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$67.00	+25.30%
2/12/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$57.00 ➝ $65.00	+21.27%
11/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$63.00 ➝ $52.00	+11.42%
11/22/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$82.00 ➝ $63.00	+36.45%
8/4/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$74.00	+31.95%
7/25/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
5/22/2023	VNET Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Upgrade
5/22/2023	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$67.00	+17.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:23 AM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 24, 2025. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

The current stock price is $61.70, which is near its one-year high of $66.24, indicating strong market performance and potential for growth.
Corteva, Inc. has a market capitalization of $42.30 billion, reflecting its significant size and stability in the agriculture sector.
The company recently announced a quarterly dividend of $0.17 per share, translating to an annualized dividend yield of 1.10%, providing a return on investment for shareholders.
Analysts have a consensus rating of "Moderate Buy" with an average price target of $68.00, suggesting that there is optimism about the stock's future performance.
Corteva's low debt-to-equity ratio of 0.08 indicates a strong financial position, meaning the company is less reliant on debt for financing, which can be a safer investment.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

The company reported earnings per share (EPS) of $0.32, which missed the consensus estimate of $0.34, indicating potential challenges in meeting market expectations.
Corteva has a relatively high price-to-earnings (P/E) ratio of 47.83, which may suggest that the stock is overvalued compared to its earnings, posing a risk for investors.
Insider ownership is only 0.20%, which may indicate a lack of confidence from those closest to the company regarding its future performance.
The company's net margin of 5.36% is relatively low, suggesting that profitability could be a concern, especially in a competitive market.
With a beta of 0.79, the stock is less volatile than the market, which may limit potential gains during bullish market conditions.

CTVA Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $68.00, with a high forecast of $74.00 and a low forecast of $55.00.
: 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CTVA shares.
: According to analysts, Corteva's stock has a predicted upside of 11.09% based on their 12-month stock forecasts.
: Over the previous 90 days, Corteva's stock had 1 upgrade by analysts.
: Corteva has been rated by research analysts at Bank of America, Barclays, BNP Paribas, Citigroup, KeyCorp, Oppenheimer, Royal Bank of Canada, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Corteva more than other "consumer staples" companies. The consensus rating score for Corteva is 2.67 while the average consensus rating score for "consumer staples" companies is 2.50. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CTVA) was last updated on 3/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target